Ameriprise’s Zoetis ZTS Stock Holding History

Ameriprise’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,500	Closed	-$3.04M	–	4198
2025 Q2	$3.04M	Buy	+19,500	New	+$3.09M	﹤0.01%	2709

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ameriprise's ZTS Position: Q2 2026 in Review

Ameriprise reduced its Zoetis (ZTS) stake by 50% in Q2 2026, selling an estimated $75.2M and leaving 812,181 shares worth $58.4M. The position accounts for 0.01% of the portfolio, ranked #864.

Ameriprise first reported a position in ZTS in Q2 2013 and has held it in 53 quarters since. The position peaked at $712M in Q1 2024. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

Ameriprise held 812,181 shares of Zoetis worth $58.4M as of Q2 2026.
Ameriprise sold 798,453 Zoetis shares in Q2 2026, an estimated $75.2M.
Zoetis made up 0.01% of Ameriprise's portfolio in Q2 2026, its #864 holding.
Ameriprise first reported a position in Zoetis in Q2 2013 and has held it in 53 quarters since.
Ameriprise's Zoetis position peaked at $712M in Q1 2024.
1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.